These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 24112791)

  • 1. Effects of the neurotrophic agent T-817MA on oligomeric amyloid-β-induced deficits in long-term potentiation in the hippocampal CA1 subfield.
    Takamura Y; Ono K; Matsumoto J; Yamada M; Nishijo H
    Neurobiol Aging; 2014 Mar; 35(3):532-6. PubMed ID: 24112791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel neurotrophic agent, T-817MA [1-{3-[2-(1-benzothiophen-5-yl) ethoxy] propyl}-3-azetidinol maleate], attenuates amyloid-beta-induced neurotoxicity and promotes neurite outgrowth in rat cultured central nervous system neurons.
    Hirata K; Yamaguchi H; Takamura Y; Takagi A; Fukushima T; Iwakami N; Saitoh A; Nakagawa M; Yamada T
    J Pharmacol Exp Ther; 2005 Jul; 314(1):252-9. PubMed ID: 15798005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ameliorative effects of a neuroprotective agent, T-817MA, on place learning deficits induced by continuous infusion of amyloid-beta peptide (1-40) in rats.
    Nguyen PT; Kimura T; Ho SA; Tran AH; Ono T; Nishijo H
    Hippocampus; 2007; 17(6):443-55. PubMed ID: 17397046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A neuroprotective agent, T-817MA (1-{3-[2-(1-benzothiophen-5-yl)ethoxy]propyl} azetidin-3-ol maleate), prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice.
    Kawasaki T; Ago Y; Kitao T; Nashida T; Takagi A; Takuma K; Matsuda T
    Neuropharmacology; 2008 Oct; 55(5):654-60. PubMed ID: 18573265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-817MA, a neurotrophic agent, ameliorates the deficits in adult neurogenesis and spatial memory in rats infused i.c.v. with amyloid-beta peptide.
    Kimura T; Hong Nguyen PT; Ho SA; Tran AH; Ono T; Nishijo H
    Br J Pharmacol; 2009 Jun; 157(3):451-63. PubMed ID: 19371351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-817MA, a neuroprotective agent, attenuates the motor and cognitive impairments associated with neuronal degeneration in P301L tau transgenic mice.
    Fukushima T; Nakamura A; Iwakami N; Nakada Y; Hattori H; Hoki S; Yamaguchi H; Nakagawa M; Terashima N; Narita H
    Biochem Biophys Res Commun; 2011 Apr; 407(4):730-4. PubMed ID: 21439944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impairment of Spike-Timing-Dependent Plasticity at Schaffer Collateral-CA1 Synapses in Adult APP/PS1 Mice Depends on Proximity of Aβ Plaques.
    Garad M; Edelmann E; Leßmann V
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic effects of oligomeric Aβ(1-42) on hippocampal synaptic plasticity in vivo].
    Tan T; Zhang BL; Tian X
    Sheng Li Xue Bao; 2011 Jun; 63(3):225-32. PubMed ID: 21681340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacological properties of T-817MA, a novel neurotrophic agent, for treatment of Alzheimer's disease.].
    Fukushima T
    Nihon Yakurigaku Zasshi; 2010 Jul; 136(1):11-4. PubMed ID: 20628207
    [No Abstract]   [Full Text] [Related]  

  • 10. T-817MA, a novel neurotrophic agent, improves sodium nitroprusside-induced mitochondrial dysfunction in cortical neurons.
    Fukushima T; Koide M; Ago Y; Baba A; Matsuda T
    Neurochem Int; 2006 Jan; 48(2):124-30. PubMed ID: 16219389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effects of T-817MA against noise-induced hearing loss.
    Yamashita D; Shiotani A; Kanzaki S; Nakagawa M; Ogawa K
    Neurosci Res; 2008 May; 61(1):38-42. PubMed ID: 18343519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-817MA, a novel neurotrophic agent, ameliorates loss of GABAergic parvalbumin-positive neurons and sensorimotor gating deficits in rats transiently exposed to MK-801 in the neonatal period.
    Uehara T; Sumiyoshi T; Hattori H; Itoh H; Matsuoka T; Iwakami N; Suzuki M; Kurachi M
    J Psychiatr Res; 2012 May; 46(5):622-9. PubMed ID: 22342346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo injected mitochondria-targeted plastoquinone antioxidant SkQR1 prevents β-amyloid-induced decay of long-term potentiation in rat hippocampal slices.
    Kapay NA; Isaev NK; Stelmashook EV; Popova OV; Zorov DB; Skrebitsky VG; Skulachev VP
    Biochemistry (Mosc); 2011 Dec; 76(12):1367-70. PubMed ID: 22150282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRZ-99030 - A novel modulator of Aβ aggregation: II - Reversal of Aβ oligomer-induced deficits in long-term potentiation (LTP) and cognitive performance in rats and mice.
    Rammes G; Gravius A; Ruitenberg M; Wegener N; Chambon C; Sroka-Saidi K; Jeggo R; Staniaszek L; Spanswick D; O'Hare E; Palmer P; Kim EM; Bywalez W; Egger V; Parsons CG
    Neuropharmacology; 2015 May; 92():170-82. PubMed ID: 25637092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulated CRTC1-BDNF signaling pathway in the hippocampus contributes to Aβ oligomer-induced long-term synaptic plasticity and memory impairment.
    Yan P; Xue Z; Li D; Ni S; Wang C; Jin X; Zhou D; Li X; Zhao X; Chen X; Cui W; Xu D; Zhou W; Zhang J
    Exp Neurol; 2021 Nov; 345():113812. PubMed ID: 34274327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-Ala2GIP facilitated synaptic plasticity and reduces plaque load in aged wild type mice and in an Alzheimer's disease mouse model.
    Faivre E; Hölscher C
    J Alzheimers Dis; 2013; 35(2):267-83. PubMed ID: 23568101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slow Release of Hydrogen Sulfide in CA1 Hippocampal Neurons Rescues Long-Term Synaptic Plasticity and Associativity in an Amyloid-β Induced Model of Alzheimer's Disease.
    Manakkadan A; Krishnan D; Rui Xia Ang S; Sajikumar S
    J Alzheimers Dis; 2024; 101(3):913-921. PubMed ID: 39302367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic nicotine restores normal Aβ levels and prevents short-term memory and E-LTP impairment in Aβ rat model of Alzheimer's disease.
    Srivareerat M; Tran TT; Salim S; Aleisa AM; Alkadhi KA
    Neurobiol Aging; 2011 May; 32(5):834-44. PubMed ID: 19464074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cocoa extracts reduce oligomerization of amyloid-β: implications for cognitive improvement in Alzheimer's disease.
    Wang J; Varghese M; Ono K; Yamada M; Levine S; Tzavaras N; Gong B; Hurst WJ; Blitzer RD; Pasinetti GM
    J Alzheimers Dis; 2014; 41(2):643-50. PubMed ID: 24957018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the Effect of Exercise on Late-Phase LTP of the Dentate Gyrus and CA1 of Alzheimer's Disease Model.
    Dao AT; Zagaar MA; Levine AT; Alkadhi KA
    Mol Neurobiol; 2016 Dec; 53(10):6859-6868. PubMed ID: 26660327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.